| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000037756 |
| Receipt No. | R000043061 |
| Scientific Title | Skin quality improvement effect by combined use of cosmetic serum and cream : single arm trial |
| Date of disclosure of the study information | 2019/09/05 |
| Last modified on | 2020/04/15 (Ver. 3) |
| Basic information | ||
| Public title | Skin quality improvement effect by combined use of cosmetic serum and cream | |
| Acronym | 2-item trial | |
| Scientific Title | Skin quality improvement effect by combined use of cosmetic serum and cream : single arm trial | |
| Scientific Title:Acronym | 2-item trial | |
| Region |
|
|
| Condition | ||
| Condition | Healthy adult woman | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Evaluate changes in skin condition before using the test article and after using it for 8 weeks |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | wrinkles, the moisture content of the skin, the texture of the skin, elasticity |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Self control |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Use two types of cosmetics and massage together | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Female | |||
| Key inclusion criteria | 1. Subjects whose wrinkle class in the outer corner is 1 to 3
2. Subjects whose skin is dry 3. Subjects with facial cheek slack |
|||
| Key exclusion criteria | 1. Subjects with cosmetic allergies
2. Subjects who are pregnant or lactating 3. Subjects with inflamed or scraped skin on face 4. Subjects who are judged as unsuitable for the study by the investigator for the other reason |
|||
| Target sample size | 18 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Japan Clinical Trial Association | ||||||
| Division name | N.A. | ||||||
| Zip code | 1600022 | ||||||
| Address | 5F, 4-3-17 Shinjuku, Shinjukuku, Tokyo | ||||||
| TEL | 0364574666 | ||||||
| info@yakujihou.org | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Japan Clinical Trial Association | ||||||
| Division name | N.A. | ||||||
| Zip code | 1600022 | ||||||
| Address | 5F, 4-3-17 Shinjuku, Shinjukuku, Tokyo | ||||||
| TEL | 0364574666 | ||||||
| Homepage URL | |||||||
| kaneko@usjri.com | |||||||
| Sponsor | |
| Institute | Japan Clinical Trial Association |
| Institute | |
| Department | |
| Funding Source | |
| Organization | ECLAT Co., Ltd |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Institutional Review Board of Pharmaceutical Law Wisdoms |
| Address | 5F, 4-3-17 Shinjuku, Shinjukuku, Tokyo |
| Tel | 0364574911 |
| master@yakujihou.net | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Published |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | 20 |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000043061 |